3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, 97%, 250mg

2-Methoxy-6-(methylamino)benzonitrile, 95.0%, 250mg

3-Bromophenylacetic Acid>95.0%(GC)(T)25g

2-Thioxo-1,2-dihydropyrimidine-5-carbaldehyde, 98%, 1g

(2R,4aR,6S,7R,8R,8aS)-6-Methoxy-2-(4-methoxyphenyl)hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol, 98%, 50mg

4-(1,2,3-Thiadiazol-4-yl)aniline, 95+%, 5g

Tert-butyln-methyl-N-{[(3S)-pyrrolidin-3-yl]methyl}carbamate, 98%, 500mg

(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 1g

ETHENESULFONYL CHLORIDE, 98.0%, 100mg

(S)-tert-Butyl 2-amino-3-phenylpropanoate, 97%, 10g

GC capillary column ROTI®Cap-5, 25 m, 0.20 mm, 0.35 µm, 1 Piece(s)

2-Bromophenyl benzyl ether, 95.0%, 5g

2-Fluoro-5-methoxy-4-nitrobenzoic acid, 97%, 25g